IDEAYA Biosciences, Inc. (IDYA)
33.85
-0.01
(-0.03%)
USD |
NASDAQ |
Oct 15, 16:00
34.38
+0.53
(+1.57%)
After-Hours: 04:41
IDEAYA Biosciences Research and Development Expense (Quarterly) : 108.69M for June 30, 2026
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 108.69M |
| March 31, 2026 | 95.73M |
| December 31, 2025 | 86.60M |
| September 30, 2025 | 82.99M |
| June 30, 2025 | 74.23M |
| March 31, 2025 | 70.89M |
| December 31, 2024 | 140.18M |
| September 30, 2024 | 57.15M |
| June 30, 2024 | 54.53M |
| March 31, 2024 | 42.80M |
| December 31, 2023 | 38.77M |
| September 30, 2023 | 33.70M |
| June 30, 2023 | 29.18M |
| March 31, 2023 | 27.86M |
| December 31, 2022 | 24.71M |
| September 30, 2022 | 22.37M |
| June 30, 2022 | 22.80M |
| Date | Value |
|---|---|
| March 31, 2022 | 19.66M |
| December 31, 2021 | 16.11M |
| September 30, 2021 | 15.50M |
| June 30, 2021 | 14.98M |
| March 31, 2021 | 11.57M |
| December 31, 2020 | 12.05M |
| September 30, 2020 | 10.02M |
| June 30, 2020 | 8.596M |
| March 31, 2020 | 9.026M |
| December 31, 2019 | 8.541M |
| September 30, 2019 | 8.923M |
| June 30, 2019 | 8.859M |
| March 31, 2019 | 7.996M |
| December 31, 2018 | 7.577M |
| September 30, 2018 | 12.54M |
| June 30, 2018 | 6.432M |
| March 31, 2018 | 5.202M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 21.96M |
| Xencor, Inc. | 71.90M |
| BioMarin Pharmaceutical, Inc. | 206.95M |
| MediciNova, Inc. | 1.024M |
| Viking Therapeutics, Inc. | 115.75M |